Rebecca LaFond

Development of a lipopeptide-based therapeutic vaccine to treat chronic HBV infection. I. Induction of a primary cytotoxic T lymphocyte response in humans.

Antonella Vitiello, Glenn Ishioka, H M Grey et al. · Journal of Clinical Investigation · 1995 · 334 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Frequency of Epitope-Specific Naive CD4+ T Cells Correlates with Immunodominance in the Human Memory Repertoire

William W. Kwok, Venus Tan, Laurie Gillette et al. · The Journal of Immunology · 2012 · 119 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +16

Failure to demonstrate long-lived MHC saturation both in vitro and in vivo. Implications for therapeutic potential of MHC-blocking peptides.

Glenn Ishioka, Luciano Adorini, Jean‐Charles Guéry et al. · The Journal of Immunology · 1994 · 57 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Seroprevalence of Antibodies to<i>Toxoplasma gondii</i>in Lynx (<i>Lynx canadensis</i>) and Bobcats (<i>Lynx rufus</i>) From Québec, Canada

Patrice LaBelle, J. P. Dubey, I. Mikaelian et al. · Journal of Parasitology · 2001 · 39 citations

Veterinary Medicine, Immunology, Veterinary Parasitology +14

Visualizing Antigen Specific CD4+ T Cells using MHC Class II Tetramers

Eddie A. James, Rebecca LaFond, Ivana Durinovic‐Belló et al. · Journal of Visualized Experiments · 2009 · 28 citations · Full text

Life Sciences, Cell Biology, Immunology +17